Animal models are critical for studies of the etiology and potential pharmacological interventions of Alzheimer's disease (AD) and other amyloidoses, including cerebral amyloid angiopathy (CAA). The histopathology of AD and CAA includes brain parenchymal and vessel wall deposits of amyloid beta-protein (Abeta), a degradation production of beta-amyloid precursor protein (betaAPP). Mutations in the betaAPP gene exist in a few families with early onset familial AD (FAD) or CAA. The mutations segregate with the diseases, implying a role in amyloidogenesis. However, the amyloid fibrils are usually processing products of a normal precursor protein suggesting that amyloid associated proteins, such as apolipoprotein E and J, may play a crucial role in amyloid formation. The goals of this project are to establish transgenic models of AD and CAA, to determine from which tissues the amyloid rises, and to study the role of apolipoproteins E and J in amyloidogenesis in transgenic animals.
The specific aims of this proposal are: 1) to develop an animal model of CAA using vascular smooth muscle, neuronal and/or liver-specific promoters directing over-expression of wild type or amyloid/Dutch mutation (HCHWA-D); 2) to reduce established and develop new models of parenchymal amyloidosis, including a study of the microanatomy of amyloid deposition using a regionally-restricted neuronal promoter; and 3) to construct transgenic animal over-expressing apolipoprotein J in astrocytes in order to study the role of this protein in solubilization of amyloid peptides. Transgene expression will be assessed using Western, ELISA immunocytochemical and in situ assays. Histopathology examinations will be performed on all animals with appropriate levels of transgene expression. Crosses of animals with amyloid deposition, vascular and/or parenchymal, will be made with animals with engineered apoJ and apoE phenotypes to assess the effects of these amyloid associated proteins on amount and rate of amyloid deposition.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010491-07
Application #
6433706
Study Section
National Institute on Aging Initial Review Group (NIA)
Project Start
2001-03-15
Project End
2002-02-28
Budget Start
Budget End
Support Year
7
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Nathan Kline Institute for Psychiatric Research
Department
Type
DUNS #
167204762
City
Orangeburg
State
NY
Country
United States
Zip Code
10962
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23

Showing the most recent 10 out of 198 publications